Advertisement

Topics

EPFL Company Profile

00:50 EST 22nd November 2017 | BioPortfolio

EPFL is one of the two Ecoles Polytechniques fédérales in Switzerland. Like its sister institution, ETHZ, it has three missions: education, research and technology transfer at the highest international level. Associated with several specialised research institutes, the two EPFs form the EPF domain, which is directly dependent on the Federal Department of Home Affairs. EPFL, in its idyllic location on the shores of Lake Geneva, brings together a campus of more than 10,000 people. By its novel structure, the school stimulates collaboration between students, professors, researchers and entrepreneurs. These daily interactions give rise to new and groundbreaking work in science, technology and architecture.

Location

CE 3 316 (Centre Est), Station 1
Lausanne
Ch-1015
Switzerland

Contact

Phone: 021 693 11 11
Email: webmaster@epfl.ch


News Articles [34 Associated News Articles listed on BioPortfolio]

EPFL Life Sciences Symposium: Frontiers in Metabolism 2017

(Ecole Polytechnique Fédérale de Lausanne) In October 24-26 we will host on campus (SwissTech Convention Center) an exciting Life Science Symposium: Frontiers in Metabolism 2017 -- From systems phys...

How the genome sets its functional micro-architecture

(Ecole Polytechnique Fédérale de Lausanne) EPFL scientists show how DNA is organized into specific regions, and that this depends on a combination of genomic distance and the presence of the CTCF pr...

Metabolism can be used to subtype hepatoblastoma tumors

Looking at cell metabolism instead of histology, EPFL scientists have identified new biomarkers that could help more accurately classify the two main subtypes of hepatoblastoma, a children liver cance...

Cell senescence is regulated by innate DNA sensing

(Ecole Polytechnique Fédérale de Lausanne) EPFL scientists have made new insights into the control of cell senescence, which is intimately linked to the development of cancer and aging.

Mitobridge licenses EFPL's NAD+ modulation IP for mitochondrial, aging diseases

Mitobridge Inc. gained exclusive worldwide rights to intellectual property related to modulating the nicotinamide adenine dinucleotide (NAD+) pathway from the Ecole Polytechnique Federale de Lausanne ...

Metabolism can be used to subtype hepatoblastoma

(Ecole Polytechnique Fédérale de Lausanne) Looking at cell metabolism instead of histology, EPFL scientists have identified new biomarkers that could help more accurately classify the two main subty...

EPFL scientists discover metabolic differences between hepatoblastoma subtypes

Hepatoblastoma is a rare pediatric liver cancer, usually diagnosed in the first three years of life. Histological methods are used to distinguish between the different subtypes of hepatoblastoma.

New Method Leads to Creation of Long-Acting Peptides

Researchers at the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland say they have developed a ligand that could potentially extend the half-life of peptides from minutes to sev...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Multi-scale modelling to evaluate building energy consumption at the neighbourhood scale.

A new methodology is proposed to couple a meteorological model with a building energy use model. The aim of such a coupling is to improve the boundary conditions of both models with no significant inc...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Enhancing Social Interaction With an AlterEgo Artificial Agent

The objective of AlterEgo is the creation of an interactive cognitive architecture, implementable in various artificial agents, allowing a continuous interaction with patients suffering fr...

Companies [8 Associated Companies listed on BioPortfolio]

EPFL

EPFL is one of the two Ecoles Polytechniques fédérales in Switzerland. Like its sister institution, ETHZ, it has three missions: education, research and technology transfer at the highest internatio...

Abionic

Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abi...

Suriasis SA

Suriasis will provide advanced chemical surface treatments to companies in the dental and orthopedic implant industry who need to better control the tissue-implant interface. Suriasis means “Healing...

Ayanda Biosystems SA

Ayanda Biosystems S.A. ("Ayanda") is a technology development company of innovative tools for medical diagnostics and drug discovery applications. Founded in June 2001, Ayanda (a South African name si...

Venture Valuation Inc.

Venture Valuation was founded in spring 1999 based on research work by the founder and CEO, Patrik Frei, at the University of St. Gallen (HSG) and the Swiss Federal Institute of Technology in Lausanne...

More Information about "EPFL" on BioPortfolio

We have published hundreds of EPFL news stories on BioPortfolio along with dozens of EPFL Clinical Trials and PubMed Articles about EPFL for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EPFL Companies in our database. You can also find out about relevant EPFL Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record